Skip to main content
logo
Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan flag Japan · Delayed Price · Currency is JPY
256.00
-3.00 (-1.16%)
May 28, 2026, 3:30 PM JST

Taiko Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
12,86414,97516,61415,08217,19335,911
Market Cap Growth
-7.14%-9.87%10.16%-12.28%-52.12%-48.57%
Enterprise Value
9,45312,21014,07013,28517,03834,790
Last Close Price
256.00298.00327.28299.60389.58814.75
PE Ratio
24.0016.2218.50---
PS Ratio
2.092.342.642.463.413.18
PB Ratio
1.561.762.092.242.142.80
P/TBV Ratio
1.561.772.092.242.202.87
P/FCF Ratio
-28.6381.04---
P/OCF Ratio
-18.4045.90---
PEG Ratio
-4.034.034.034.034.03
EV/Sales Ratio
1.531.912.242.173.383.08
EV/EBITDA Ratio
16.1816.8615.88---
EV/EBIT Ratio
29.8226.6022.33---
EV/FCF Ratio
-23.3568.64---
Debt / Equity Ratio
0.050.100.260.480.470.37
Debt / EBITDA Ratio
0.721.132.29---
Debt / FCF Ratio
-1.569.89---
Net Debt / Equity Ratio
-0.41-0.40-0.31-0.330.04-0.10
Net Debt / EBITDA Ratio
-5.84-4.75-2.837.38-0.130.33
Net Debt / FCF Ratio
--6.58-12.225.52-0.150.43
Asset Turnover
0.530.510.480.430.270.42
Inventory Turnover
1.511.771.722.131.541.78
Quick Ratio
2.972.672.442.451.902.35
Current Ratio
4.143.363.072.992.713.19
Return on Equity (ROE)
6.60%11.20%12.22%-48.86%-46.96%-53.92%
Return on Assets (ROA)
1.69%2.28%3.01%-4.45%-10.24%-11.39%
Return on Invested Capital (ROIC)
6.39%8.40%12.64%-15.65%-31.05%-33.64%
Return on Capital Employed (ROCE)
3.30%4.70%6.30%-9.90%-25.10%-27.20%
Earnings Yield
4.17%6.16%5.41%-23.94%-28.47%-26.72%
FCF Yield
-3.49%1.23%-2.68%-11.97%-8.55%
Dividend Yield
1.35%1.11%----
Payout Ratio
--0.11%---
Buyback Yield / Dilution
-0.11%-0.11%-5.96%-8.62%-0.21%-0.35%
Total Shareholder Return
1.25%1.00%-5.96%-8.62%-0.21%-0.35%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.